Wegovy: Novo Nordisk's experimental drug

Novo Nordisk's experimental drug, CagriSema, shows promise beyond weight loss, potentially offering significant cardiovascular benefits. This next-ge Wegovy 1.7mg FlexTouch promotes significant and lasting weight loss in adults who are obese (a BMI of 30 or higher) or overweight (a BMI of 27 or higher) with at least one co-existing condition like high blood pressure, type 2 diabetes, or deranged lipid levels. It works by mimicking natural hormones to enhance insulin secretion and regulate appetite. It supports weight management and overall health when combined with long-term lifestyle changes, including a reduced-calorie diet and regular ... Wegovy 2.4mg FlexTouch promotes significant and lasting weight loss in adults who are obese (a BMI of 30 or higher) or overweight (a BMI of 27 or higher) with at least one co-existing condition like high blood pressure, type 2 diabetes, or deranged lipid levels. It works by mimicking natural hormones to enhance insulin secretion and regulate appetite. It supports weight management and overall health when combined with long-term lifestyle changes, including a reduced-calorie diet and regular ... Discover how Wegovy ® (semaglutide) aids in adults with obesity or some with overweight. See Prescribing Info & Medication Guide.